Sihuan Pharmaceutical Holdings Group (HK:0460) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sihuan Pharmaceutical Holdings Group Ltd. has made a strategic move by purchasing 5 million shares for its 2022 Share Award Scheme, representing a modest 0.05% of the company’s total shares. The buy was executed at an average price of HK$0.5918 per share. The company, renowned for its medical aesthetics and biopharmaceutical endeavors, aims to solidify its position as a market leader in China.
For further insights into HK:0460 stock, check out TipRanks’ Stock Analysis page.